REF-508 · Robinson, Hamilton & Miller, 2009 · Journal of Applied Physiology, Vol. · Paper · PubMed

The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise

C+thin evidenceMeasured on a mixed groupWritten before October 2026, being re-checked

Key Findings

Premise (abstract): mitochondrial dysfunction drives chronic-disease progression; many drugs prescribed for those diseases have been shown to induce mitochondrial dysfunction; exercise is recommended alongside them as a mitochondrial-biogenesis stimulus
The interference of those drugs with exercise-induced mitochondrial adaptation "has not been thoroughly investigated" — the review summarises known and potential interactions
Full text; not checked against the abstract: the review covers statins, metformin, NSAIDs and antioxidants and discusses redox (ROS) signalling as a shared route by which they might blunt training-induced mitochondrial biogenesis
Organizing takeaway: any chronic pharmacological/nutraceutical intervention on redox status potentially modulates the training response — a hypothesis to keep in view, not an established effect

Practical Application (not medical advice)

A 2009 mechanistic review: drugs commonly prescribed for chronic disease can induce mitochondrial dysfunction, exercise drives mitochondrial biogenesis, and whether the two interact had not been thoroughly investigated — the paper maps known and potential interactions, it does not quantify them. Use it as the reason to ask "could my medication blunt adaptation?", not as evidence that it does.
Not from this paper; the base's own practice: keep routine high-dose antioxidant supplements away from key adaptation sessions and do not lean on chronic NSAID use to "push through" training; the statin evidence is in REF-503 and REF-504, the cold-water-immersion analogue (a recovery intervention that attenuates strength adaptation) in REF-011

Limitations

Mechanistic review from 2009; some redox-interference hypotheses have since been refined/contested
The abstract states no data, effect sizes or drug-specific conclusions; every drug-specific claim is from the full text
Clinical relevance for trained masters athletes specifically not established
How this entry was checked and changed
Why this level

regraded 2026-09-27 from B: narrative review without systematic method; the abstract carries no data

Content correction 2026-09-27
Level B -> C+ per KB-LEVEL-RUBRIC (narrative review without systematic method). Sport "running, strength, hybrid" -> "general" (a review with no sport population).
Drug-specific mechanisms (PGC-1α/ROS signalling, statins, NSAIDs, antioxidants) labelled as full-text content not in the abstract; the antioxidant/NSAID timing advice labelled as the base's own practice.
Cross-reference "REF-009 tart cherry (does not block mTOR, unlike NSAIDs)" removed — REF-009 did not test NSAIDs or mTOR; "REF-357 antioxidant/omega-3 context" removed — REF-357 is omega-3, not antioxidant interference.